Drug Shortage Report for APO-VALSARTAN/HCTZ

Last updated on 2019-03-21 History
Report ID 546
Drug Identification Number 02382563
Brand name APO-VALSARTAN/HCTZ
Common or Proper name VALSARTAN/HCTZ
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) HYDROCHLOROTHIAZIDE VALSARTAN
Strength(s) 25MG 160MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL & 500 BTL & 30 BLS
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-01-04
Estimated end date
Actual end date 2018-12-28
Shortage status Resolved
Updated date 2019-03-21
Company comments Product Discontinued
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-03-21 French Compare
v3 2019-03-21 English Compare
v2 2017-03-11 French Compare
v1 2017-03-11 English Compare

Showing 1 to 4 of 4